MEngSc in Biopharmaceutical Engineering  (T070)

The MEngSc Biopharmaceutical Engineering programme provides intensive training in the requisite skills for a professional engineer or scientist in the biopharmaceutical or related sector. The programme provides substantial coverage of the scientific, technical, management and regulatory issues associated with this industry. 

The programme's teaching methods are highly interactive and varied and student learning is assessed using a variety of assessment methodology including exams, assignments, case studies and presentations.  Students complete a research project which consolidates their basic knowledge of the course content and provides intensive research experience and training. The course content addresses the principal scientific and engineering challenges involved in the design, operation and management of biopharmaceutical production facilities. 

It is anticipated that graduates from this programme will play an important role in the development, design and operation of biopharmaceutical processes throughout the industry in the coming years.

1 - Demonstrate an understanding of the scientific principles involved in the development of a biopharmaceutical production process
2 - Understand the engineering principles underlying the production of biopharmaceuticals
3 - Demonstrate an integrated knowledge of GMP and the regulatory issues involved in biopharmaceutical production
4 - Apply their knowledge of biopharmaceutical production processes to design, equip and manage a biopharmaceutical production factility
5 - Demonstrate the ability to work as part of a design team for the development of a new production facility
6 - Demonstrate an understanding and appreciation of the challenges involved in the downstream purification of biopharmaceuticals
7 -
8 -
9 - Demonstrate an understanding of the fundamentals of process control when applied to growth of mammalian cells in bioreactors
10 - Demonstrate an appreciation of the concept and practice of independent research in specialised topics in biopharmaceutical engineering

Graduates from this programme are highly sought after and play an important role in the development, design and operation of biopharmaceutical processes throughout the industry in the coming years.  Ireland is a world player in pharmaceutical and biopharmaceutical production. 

The pharmaceutical industry in Ireland comprises a mix of international and local companies. Approximately, 120 overseas companies have plants in Ireland, including many of the largest pharmaceutical and biopharmaceutical companies in the world including AbbVie, Amgen, Biomarin, BMS, Genzyme, GSK, Janssen Biologics (Ireland), Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Shire, and many more. Upon graduation from this programme, you will enjoy an extremely high job placement rate with superlative career opportunities.

Stage 1

T070 MEngSc Biopharmaceutical Engineering FT is a 1-Year, 90-credit full-time Masters Programme.

See the UCD Assessment website for further details

---

Module Weighting Info